MIVZAK.
Health

Teva drug meets endpoints in celiac disease trial

Globes English
Teva drug meets endpoints in celiac disease trial

The antibody TEV ‘408 (anti-IL 15) was also tested as a treatment for the skin disease vitiligo, and there it also presented encouraging findings.

More in this section